Objective:To establish a simpler, quicker method for detecting the minimal residual disease.
目的：建立一种简便、快速的微小残留病的检测方法。
Objective To improve the techniques for minimal residual disease (MRD) detection in acute lymphoblastic leukemia (ALL).
目的探索提高急性淋巴细胞白血病(all)微量残留病(MRD)检测技术。
Whether minimal residual disease results in clinical metastases is a function of host defense and tumor survival and growth.
微小转移瘤是否可以导致临床上肿瘤的转移，取决于宿主的防御功能和肿瘤的侵袭能力。
Conclusion Monitoring of the WT1 gene by Nest RTPCR would be a surely marker for the detection of minimal residual disease (MRD) in acute leukemia.
结论用Nest、RT - PCR测定WT 1基因的表达可作为检测白血病微小残留病(MRD)的一项指标。
Objective to investigate the significance of serial monitoring of minimal residual disease (MRD) in patients with acute lymphoblastic leukemia (ALL).
目的探讨急性淋巴细胞白血病(all)微量残留病(MRD)检测的临床意义。
Gene markers which are used to detect minimal residual disease(MRD)include fusion genes(FG), aberrant genes and some genes with high expression in leukemia disease.
残留白血病检测的基因标志可大致分为融合基因、变异基因和一些白血病中表达增高的基因。
Even though a lot of advances are made in the therapy of malignant tumors, it is difficult to eliminate the minimal residual disease by chemotherapy, radiotherapy and operation.
恶性肿瘤的治疗已有很多进展，但微小残留病灶仍难以被现行的化疗、放疗、手术等方案彻底清除。
Objective:To explore whether detecting minimal residual disease of leukemia with hyper-methylation of the calcitonin gene as molecular genetic marker of leukemic clone to predict the prognosis.
目的：探讨以降钙素基因高度甲基化为白血病克隆的分子基因标志，检测白血病微量残留病，并预测预后的可能性。
Objective:To explore whether detecting minimal residual disease of leukemia with hyper-methylation of the calcitonin gene as molecular genetic marker of leukemic clone to predict the prognosis.
目的：探讨以降钙素基因高度甲基化为白血病克隆的分子基因标志，检测白血病微量残留病，并预测预后的可能性。
应用推荐